Abstract |
Interkingdom polymicrobial biofilms formed by Gram-positive Staphylococcus aureus and Candida albicans pose serious threats of chronic systemic infections due to the absence of any common therapeutic target for their elimination. Herein, we present the structure-activity relationship (SAR) of membrane-targeting cholic acid- peptide conjugates (CAPs) against Gram-positive bacterial and fungal strains. Structure-activity investigations validated by mechanistic studies revealed that valine- glycine dipeptide-derived CAP 3 was the most effective broad-spectrum antimicrobial against S. aureus and C. albicans CAP 3 was able to degrade the preformed single-species and polymicrobial biofilms formed by S. aureus and C. albicans, and CAP 3-coated materials prevented the formation of biofilms. Murine wound and catheter infection models further confirmed the equally potent bactericidal and fungicidal effect of CAP 3 against bacterial, fungal, and polymicrobial infections. Taken together, these results demonstrate that CAPs, as potential broad-spectrum antimicrobials, can effectively clear the frequently encountered polymicrobial infections and can be fine-tuned further for future applications.
|
Authors | Siddhi Gupta, Jyoti Thakur, Sanjay Pal, Ragini Gupta, Deepakkumar Mishra, Sandeep Kumar, Kavita Yadav, Amandeep Saini, Prabhu S Yavvari, Madhukar Vedantham, Archana Singh, Aasheesh Srivastava, Rajendra Prasad, Avinash Bajaj |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 63
Issue 11
(11 2019)
ISSN: 1098-6596 [Electronic] United States |
PMID | 31427303
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 American Society for Microbiology. |
Chemical References |
- Anti-Infective Agents
- Peptides
- Cholic Acid
|
Topics |
- Animals
- Anti-Infective Agents
(pharmacology)
- Biofilms
(drug effects)
- Candida albicans
(drug effects)
- Candidiasis
(drug therapy, microbiology)
- Cholic Acid
(pharmacology)
- Male
- Mice
- Mice, Inbred BALB C
- Microbial Sensitivity Tests
(methods)
- Microbial Viability
(drug effects)
- Peptides
(pharmacology)
- Staphylococcal Infections
(drug therapy, microbiology)
- Staphylococcus aureus
(drug effects)
|